Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy
Abstract Although metabolic intratumoral heterogeneity (ITH) gives important value on treatment responses and prognoses, its association with treatment outcomes have not been reported in gastric cancer (GC). We aimed to evaluate temporal changes in metabolic ITH and the associations with treatment r...
Main Authors: | Shin Hye Yoo, Seo Young Kang, Jeesun Yoon, Tae-Yong Kim, Gi Jeong Cheon, Do-Youn Oh |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-78963-2 |
Similar Items
-
Prediction of Recurrence by Preoperative Intratumoral FDG Uptake Heterogeneity in Endometrioid Endometrial Cancer
by: Seo Young Kang, et al.
Published: (2017-04-01) -
Combination versus single-agent as palliative chemotherapy for gastric cancer
by: Jin-Hyuk Choi, et al.
Published: (2020-03-01) -
Assessment of intratumoral heterogeneity with mutations and gene expression profiles.
by: Ji-Yong Sung, et al.
Published: (2019-01-01) -
Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses
by: Soon‐Chan Kim, et al.
Published: (2022-02-01) -
Intratumor heterogeneity and cell secretome promote chemotherapy resistance and progression of colorectal cancer
by: Julia Källberg, et al.
Published: (2023-05-01)